4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000053
Chief Scientific Officer sold 3,242 shares at an average $15.12 ($49,004)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sethuraman Natarajan Chief Scientific Officer | 2024-09-06 | Sale 10b5-1 | −600 | $15.24 | $9,141 | 186,458 | D |
| Sethuraman Natarajan Chief Scientific Officer | 2024-09-09 | Sale 10b5-1 | −2,642 | $15.09 | $39,862 | 183,816 | D |
| Open-market sales · 3,242 sh · avg $15.12 · $49,004 | |||||||
Loading xslF345X05/wk-form4_1726000325.xml…